- 25 November, 2024
Foreign Affairs, Geopolitics & National Securityvaccine
Kremlin says Sputnik Light is a valid standalone vaccine
MOSCOW (Reuters) - The Kremlin insisted on Monday that Russian-developed Sputnik Light was a standalone COVID-19 vaccine, after Russia's health minister was quoted as saying it would be used only…
G 20 leaders Summit, Rome, Italy – Special Briefing by Mr Piyush Goyal
Prime Minister Narendra Modi led the Indian Delegation to Rome to participate in the G20 Leaders Summit, which happened after a gap of 2 years. The Prime Minister also had…
Senior figures urge G20 to create new ways of tackling health threat
By Crispian Balmer ROME (Reuters) - The world's 20 richest countries must overcome differences to urgently set up new global mechanisms to confront future health disasters, a group of senior…
Switzerland recommends COVID-19 booster shots for over 65s, but not general population
BERLIN (Reuters) -Switzerland said on Tuesday it was recommending COVID-19 booster shots for people over 65 but not for the general population. The vaccinations would start from mid-November and should…
Moderna says its COVID-19 vaccine protective, safe in young children
By Manas Mishra (Reuters) -Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to submit…
India crosses One Billion Vaccinations, PM Modi expresses gratitude to doctors and nurses on crossing 100 crore vaccinations
The Prime Minister, Shri Narendra Modi has expressed gratitude to doctors, nurses and all those who worked on crossing 100 crore vaccinations. In a tweet, the Prime Minister said; "India scripts…
U.S. says delivering on vaccine pledge to Asia key to Quad credibility
WASHINGTON (Reuters) - Delivering on a pledge to supply COVID-19 vaccine doses to Southeast Asia is critical to the credibility of the Quad group of countries, which made the commitment…
Delta subvariant won’t change COVID picture, Oxford vaccine chief says
LONDON (Reuters) - A subvariant of Delta that is growing in England is being monitored but is not likely to change the COVID-19 picture, Oxford Vaccine Group chief Andrew Pollard…
India’s vaccine effort slows as dose gap trumps output jump
By Krishna N. Das NEW DELHI (Reuters) - India's vaccination campaign has slowed despite amassing record stockpiles of vaccine, health ministry data showed on Monday, as authorities maintain a wider-than-usual…
WHO advises additional COVID shot for immunocompromised people
By Stephanie Nebehay and Emma Farge GENEVA (Reuters) -The World Health Organization on Monday recommended that immunocompromised people be given an additional dose of COVID-19 vaccine, due to their higher…
U.S. will accept WHO-approved COVID-19 vaccines for international visitors
By David Shepardson WASHINGTON (Reuters) -The United States will accept the use by international visitors of COVID-19 vaccines authorized by U.S. regulators or the World Health Organization, the Centers for…
India allows Serum Institute to enrol 7-11 year olds in Novavax COVID-19 vaccine trial
BENGALURU (Reuters) -India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of U.S. drugmaker Novavax's COVID-19 vaccine, as the country…
